作者：
Marton,König [1]
;
Åslaug Rudjord,Lorentzen [2]
;
Hilde Marie,Torgauten [3]
;
The Trung,Tran [4]
;
Stine,Schikora-Rustad [5]
;
Eline Benno,Vaage [6]
;
Åse,Mygland [2]
;
Stig,Wergeland [6]
;
Jan,Aarseth [2]
;
Ingeborg Aase S,Aaberge [5]
;
Øivind,Torkildsen [7]
;
Trygve,Holmøy [8]
;
Tone,Berge [7]
;
Kjell-Morten,Myhr [8]
;
Hanne Flinstad,Harbo [9]
;
Jan Terje,Andersen [5]
;
Ludvig Andre,Munthe [7]
;
Arne,Søraas [10]
;
Elisabeth Gulowsen,Celius [11]
;
John Torgils,Vaage [12]
;
Fridtjof,Lund-Johansen [13]
;
Gro Owren,Nygaard [4]
作者单位：
Department of Neurology, Oslo University Hospital, Oslo, Norway makoni@ous-hf.no.
[1]
Department of Neurology, Sørlandet Sykehus HF, Kristiansand, Norway.
[2]
The Norwegian National Advisory Unit on Tick-borne Diseases, Arendal, Norway.
[3]
Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
[4]
Institute of Clinical Medicine, University of Bergen, Bergen, Norway.
[5]
Department of Immunology, Oslo University Hospital, Oslo, Norway.
[6]
Department of Neurology, Haukeland University Hospital, Bergen, Norway.
[7]
Norwegian MS Registry and Biobank, Haukeland University Hospital, Bergen, Norway.
[8]
Department of Infectious Disease Immunology, Norwegian Institute of Public Health, Oslo, Norway.
[9]
Department of Neurology, Akershus University Hospital, Lorenskog, Norway.
[10]
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
[11]
Department of Mechanical, Electronic and Chemical Engineering, Oslo Metropolitan University, Oslo, Norway.
[12]
Department of Research, Innovation and Education, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
[13]
Department of Neurology, Oslo University Hospital, Oslo, Norway.
[14]
Department of Pharmacology, Oslo University Hospital, Oslo, Norway.
[15]
K.G. Jebsen Centre for B cell malignancies, University of Oslo, Oslo, Norway.
[16]
Department of Microbiology, Oslo University Hospital, Oslo, Norway.
[17]
DOI
10.1136/jnnp-2021-327612
PMID
34670844
发布时间
2023-02-01
换一批
换一批
